BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.82 EUR
0.71%
Updated:
May 3, 2024
BRAIN Biotech AG
Operating Expenses
|
BRAIN Biotech AG
Operating Expenses Peer Comparison
Comparables:
WCH
EVK
1COV
ACT
SY1
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
Operating Expenses
-€36.7m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
Operating Expenses
-€718.4m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
|
Evonik Industries AG
XETRA:EVK
|
Operating Expenses
-€2.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Covestro AG
XETRA:1COV
|
Operating Expenses
-€2.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
Operating Expenses
-€251m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
Operating Expenses
-€1.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-10%
|
See Also
What is BRAIN Biotech AG's Operating Expenses?
Operating Expenses
-36.7m
EUR
-36.7m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Operating Expenses amounts to -36.7m EUR.
What is BRAIN Biotech AG's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-2%
-2%
Over the last year, the Operating Expenses growth was -5%. The average annual Operating Expenses growth rates for BRAIN Biotech AG have been -7% over the past three years , -2% over the past five years .
You don't have any saved screeners yet
